O
ARNA

OrbiMed’s Arena Pharmaceuticals Inc ARNA Stock Holding History

OrbiMed’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-66,700
Closed -$4.99M – 166
2020
Q3 		$4.99M Hold
66,700
– – 0.06% 128
2020
Q2 		$4.2M Sell
66,700
-66,700
-50% -$3.67M 0.06% 122
2020
Q1 		$5.6M Buy
133,400
+23,400
+21% +$1.07M 0.09% 103
2019
Q4 		$5M Hold
110,000
– – 0.07% 106
2019
Q3 		$5.04M Hold
110,000
– – 0.1% 94
2019
Q2 		$6.45M Buy
+110,000
New +$5.69M 0.1% 101

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

OrbiMed's ARNA Position: Q4 2020 in Review

OrbiMed sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 66,700 shares — an estimated $4.99M sold.

OrbiMed first reported a position in ARNA in Q2 2019 and held it in 6 quarters. The position peaked at $6.45M in Q2 2019. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • OrbiMed reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • OrbiMed sold 66,700 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $4.99M.
  • OrbiMed first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 6 quarters.
  • OrbiMed's Arena Pharmaceuticals Inc position peaked at $6.45M in Q2 2019.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on OrbiMed's 13F filing for Q4 2020, filed 16 Feb 2021.